Surviving Sepsis Campaign: Guidelines for Management of Sepsis and Septic Shock 2026

• In Sepsis
• Wed, 25 Mar 2026

The Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026, presented at the SCCM Congress this week, provide updated, evidence-based recommendations for the identification and management of sepsis across hospital, prehospital, and immediate post-hospital settings. Sepsis is defined as life-threatening organ dysfunction due to infection and remains a major global health burden, with approximately 49 million cases and 13 million deaths annually. Early recognition and timely intervention are emphasised as central to improving outcomes, alongside consideration of long-term physical, cognitive, and psychological sequelae among survivors.

The guidelines were developed by an international, multidisciplinary panel representing 23 countries, including significant representation from low- and middle-income settings. Using the GRADE methodology and an Evidence-to-Decision framework, recommendations were categorised as strong or conditional based on evidence certainty, balance of benefits and harms, patient values, and resource considerations. In addition to formal recommendations, the document includes good practice statements and “in our practice” insights to guide clinicians in areas of limited evidence.

A major focus is system-level improvement. The guidelines strongly recommend that hospitals implement performance improvement programmes incorporating sepsis screening, standardised treatment protocols, and quality improvement (QI) strategies. Evidence suggests that such programmes enhance adherence to best practices and may reduce mortality. QI initiatives—such as early warning systems, education, and audit-feedback loops—are particularly emphasised as scalable interventions that improve both processes of care and patient outcomes. Additionally, the use of multidisciplinary “code sepsis” or “sepsis huddle” protocols is suggested to expedite diagnosis and treatment, although evidence is of low certainty.

Screening and early identification are critical. In prehospital settings, the guidelines suggest using structured screening tools to identify high-risk patients and enable early notification of receiving hospitals. Within hospitals, early warning scores such as NEWS, NEWS2, MEWS, or SIRS are recommended over qSOFA as single screening tools due to higher sensitivity. While qSOFA remains useful for identifying clinical deterioration, it is not recommended alone for screening. Importantly, sepsis remains a clinical diagnosis and cannot be ruled in or out by a single biomarker; novel diagnostic tests may assist risk stratification but lack sufficient evidence to support routine use.

Prompt investigation and antimicrobial management are emphasised. Blood cultures should be obtained as soon as possible, ideally before antibiotic administration, to guide targeted therapy and support antimicrobial stewardship. However, this should not delay treatment. Early antimicrobial therapy is identified as the most effective intervention to reduce mortality. For patients with septic shock or definite/probable sepsis, antibiotics should be administered immediately, ideally within one hour of recognition. For possible sepsis without shock, a brief period (up to three hours) of rapid evaluation is acceptable before initiating treatment if diagnostic uncertainty exists.

Fluid resuscitation remains a cornerstone of management. The guidelines suggest administering at least 30 mL/kg of intravenous crystalloid within the first three hours for patients with sepsis-induced hypoperfusion or septic shock, while emphasising frequent reassessment to avoid fluid overload or under-resuscitation. This recommendation is based on observational evidence and remains consistent with prior guidelines. Vasopressor therapy should follow fluid resuscitation if hypotension persists, although early concurrent use may be appropriate in unstable patients. Peripheral initiation of vasopressors is suggested to avoid delays associated with central access, reflecting evolving evidence on safety and feasibility.

Haemodynamic targets are also addressed. A mean arterial pressure (MAP) of 65 mmHg is recommended as the initial target in septic shock, with a slightly lower range (60–65 mmHg) suggested for patients aged 65 years or older. Evidence indicates no mortality benefit from higher targets and a potential increase in adverse effects such as arrhythmias.

Source control is identified as a fundamental component of sepsis management. Clinicians should rapidly evaluate for infection sources requiring intervention, such as abscesses or infected devices, and aim to achieve source control as early as possible, ideally within six hours. Although evidence is largely observational, timely intervention is associated with improved outcomes.

The guidelines also address prehospital care, suggesting that antibiotics may be administered during transport for patients with septic shock if delays to hospital treatment are expected. However, feasibility varies across healthcare systems, particularly in resource-limited settings.

Throughout, the guidelines emphasise balancing rapid treatment with antimicrobial stewardship. While early antibiotics are life-saving, unnecessary use carries risks including resistance and adverse effects. Clinical judgement, supported by structured assessment and diagnostic tools, is therefore essential.

In conclusion, the 2026 guidelines reinforce that sepsis is a medical emergency requiring rapid, coordinated, and system-wide responses. Key priorities include early recognition, prompt antimicrobial therapy, appropriate fluid resuscitation, timely vasopressor support, and effective source control. Equally important are institutional strategies such as performance improvement programmes and multidisciplinary response systems. Despite advances, many recommendations remain based on low-certainty evidence, highlighting the need for ongoing research to refine optimal strategies and improve global sepsis outcomes.

Source: Intensive Care Medicine

Image Credit: SCCM Congress 2026